Fuentes et al (33) demonstrated that S100P interacted with the receptor for advanced glycation end-products (RAGE) to stimulate SW480 colon cancer cell growth and migration and upregulate ErK phosphorylation and NF-κB activation in vitro. Here, S100P is linked to colonic neoplasm.